EGFR and breast carcinoma: Recently, Hsia et al., found that lapatinib-induced breast cancer invasiveness is caused by the downregulation of miRNA-7 and induction of epidermal growth factor receptor (EGFR) and COX-2 by a HuR-mediated posttranscriptional mechanism [155].